In its role as leader of the Male Circumcision Consortium (MCC), FHI 360 worked with the Government of Kenya to expand access to safe and voluntary male circumcision services.
The MCC was formed after definitive studies in three African countries identified male circumcision as an effective tool for HIV prevention. These clinical trials, conducted in Kenya, South Africa and Uganda, showed that being circumcised reduced a man's risk of HIV infection through vaginal sex by about 60 percent.
The consortium's activities were primarily focused in western Kenya, but the knowledge it generated guided the government's national initiative on male circumcision and may also inform other countries' approaches to male circumcision for HIV prevention.
From 2007 to 2014, the MCC:
- Supported the Government of Kenya to develop and implement a national male circumcision strategy for a program that had reached 792,000 men and boys by the end of 2013
- Conducted research to identify the safest, most effective ways to provide voluntary medical male circumcision
- Identified and addressed misunderstandings about male circumcision for HIV prevention
- Assessed the acceptability, feasibility and cost of using the PrePex device to perform male circumcisions in routine clinical settings in Kenya
- Leveraged a research and training facility in western Kenya to train male circumcision providers, build the capacity of health facilities and monitor clinical outcomes
FHI 360’s partners in the consortium were EngenderHealth and the University of Illinois, working with the Nyanza Reproductive Health Society.
View a short documentary that the MCC produced about male circumcision for HIV prevention in Kenya.
More information about voluntary medical male circumcision is available at the Clearinghouse on Male Circumcision for HIV Prevention, a website managed by FHI 360.